Due to the similarity of the structure of MM-129 to roscovitine, which attenuates tumor PD-L1 expression and promotes antitumor immunity, we decided to check whether a new 1,2,4-triazine derivative can also promote an immunological anti-tumor response [49]. Here, CD274 is linked to neoplasm.